Washington G-2 Reports estimates that laboratory service revenue from Pap testing topped $1.5 billion last year and will continue to grow. Meanwhile, more than 80% of the Pap test market is dominated by two companies: Cytyc (Marlborough, MA) and TriPath Imaging (Burlington, NC), which is now owned by Becton, Dickinson (see pg. 9). Both companies market a mono-layer Pap test (versus traditional smears). The Cytyc product, ThinPrep, was approved by the FDA in May 1996. The TriPath Imaging system, SurePath, was approved by the FDA in June 1999.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

January 2007 - Table of Contents

LIR January 2007 (full PDF issue)

Competitive Bidding Demo in Holding Pattern Awaiting OMB’s OK

Sonic to Acquire American Esoteric Laboratories for $180M

LabCorp Buys Kansas Lab

What Does ’07 Hold for LabCorp? LIR’s Interview With New CEO Dave King

Lab Industry Awaits First Domino of Competitive Bidding Project to Tip

Spotlight on Pap Testing: Monolayer Testing to Take 100% of Market in ’07?

BD Closes on $350m TriPath Acquisition

Luminex to Buy Tm Bioscience for $37.9M

Aetna Contracts With Genomic Health for Oncotype DX

Lab Stocks Rise 4%; Clarient and Genomic Health Soar 27%

Integrating MDx Conference